Composition and properties of silver-containing calcium carbonate–calcium phosphate bone cement
Author(s) -
Sylvaine Jacquart,
Robin Siadous,
Christel Henocq-Pigasse,
Reine Bareille,
Christine Roques,
Christian Rey,
Christèle Combes
Publication year - 2013
Publication title -
journal of materials science materials in medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.644
H-Index - 125
eISSN - 1573-4838
pISSN - 0957-4530
DOI - 10.1007/s10856-013-5014-2
Subject(s) - materials science , calcium , calcium carbonate , composition (language) , cement , calcium phosphate cement , phosphate , mineralogy , chemical engineering , metallurgy , composite material , organic chemistry , chemistry , linguistics , philosophy , engineering
The introduction of silver, either in the liquid phase (as silver nitrate solution: Ag(L)) or in the solid phase (as silver phosphate salt: Ag(S)) of calcium carbonate-calcium phosphate (CaCO3-CaP) bone cement, its influence on the composition of the set cement (C-Ag(L) and C-Ag(S) cements with a Ca/Ag atomic ratio equal to 10.3) and its biological properties were investigated. The fine characterisation of the chemical setting of silver-doped and reference cements was performed using FTIR spectroscopy. We showed that the formation of apatite was enhanced from the first hours of maturation of C-Ag(L) cement in comparison with the reference cement, whereas a longer period of maturation (about 10 h) was required to observe this increase for C-Ag(S) cement, although in both cases, silver was present in the set cements mainly as silver phosphate. The role of silver nitrate on the setting chemical reaction is discussed and a chemical scheme is proposed. Antibacterial activity tests (S. aureus and S. epidermidis) and in vitro cytotoxicity tests (human bone marrow stromal cells (HBMSC)) showed that silver-loaded CaCO3-CaP cements had antibacterial properties (anti-adhesion and anti-biofilm formation) without a toxic effect on HBMSC cells, making C-Ag(S) cement a promising candidate for the prevention of bone implant-associated infections.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom